{
     "PMID": "15081388",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040628",
     "LR": "20151119",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "1008",
     "IP": "1",
     "DP": "2004 May 15",
     "TI": "Dimemorfan enhances acetylcholine release from rat hippocampal slices.",
     "PG": "113-5",
     "AB": "Our previous study reported that an antitussive drug, dimemorfan, attenuates cholinergic dysfunction-induced amnesia in mice and acts like a sigma1 receptor agonist. This study further showed that dimemorfan (30 microM), like the putative sigma1 receptor agonist (+)-SKF-10047 (10 microM), significantly enhanced 25 mM KCl-evoked [3H]acetylcholine release from rat hippocampal but not striatal slices, which was antagonized by a sigma1 receptor antagonist haloperidol (0.3 microM).",
     "FAU": [
          "Wang, Hui-Hung",
          "Chou, Yueh-Ching",
          "Liao, Jyh-Fei",
          "Chen, Chieh-Fu"
     ],
     "AU": [
          "Wang HH",
          "Chou YC",
          "Liao JF",
          "Chen CF"
     ],
     "AD": "Department and Institute of Pharmacology, National Yang-Ming University, No. 155, Sec. 2, Li-Nong Street, Taipei, Taiwan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Antipsychotic Agents)",
          "0 (Cholinergic Agonists)",
          "0 (Dopamine Agonists)",
          "0 (Dopamine Antagonists)",
          "0 (Morphinans)",
          "0 (Muscarinic Antagonists)",
          "10028-17-8 (Tritium)",
          "623OAC38YU (dimemorfan)",
          "660YQ98I10 (Potassium Chloride)",
          "67287-49-4 (2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine)",
          "7619-35-4 (SK&F 10047)",
          "7C0697DR9I (Atropine)",
          "8Y164V895Y (Carbachol)",
          "J0ND6N0AQC (Phenazocine)",
          "J6292F8L3D (Haloperidol)",
          "N9YNS0M02X (Acetylcholine)"
     ],
     "SB": "IM",
     "MH": [
          "2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology",
          "Acetylcholine/*metabolism",
          "Animals",
          "Antipsychotic Agents/pharmacology",
          "Atropine/pharmacology",
          "Carbachol/pharmacology",
          "Cholinergic Agonists/pharmacology",
          "Dopamine Agonists/pharmacology",
          "Dopamine Antagonists/pharmacology",
          "Dose-Response Relationship, Drug",
          "Drug Interactions",
          "Haloperidol/pharmacology",
          "Hippocampus/*drug effects/metabolism",
          "In Vitro Techniques",
          "Male",
          "Morphinans/*pharmacology",
          "Muscarinic Antagonists/pharmacology",
          "Phenazocine/*analogs & derivatives/pharmacology",
          "Potassium Chloride/pharmacology",
          "Rats",
          "Tritium/metabolism"
     ],
     "EDAT": "2004/04/15 05:00",
     "MHDA": "2004/06/29 05:00",
     "CRDT": [
          "2004/04/15 05:00"
     ],
     "PHST": [
          "2004/02/03 00:00 [accepted]",
          "2004/04/15 05:00 [pubmed]",
          "2004/06/29 05:00 [medline]",
          "2004/04/15 05:00 [entrez]"
     ],
     "AID": [
          "10.1016/j.brainres.2004.02.014 [doi]",
          "S0006899304002598 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2004 May 15;1008(1):113-5. doi: 10.1016/j.brainres.2004.02.014.",
     "term": "hippocampus"
}